Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 03 - 15    entities : Gilead sciences, inc.    save search

Merck to Host Investor Briefing to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.21% H: 1.4% C: 0.97%
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
| | O: 1.28% H: 1.32% C: 1.15%

collaboration hiv announces collaboration
Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.21% H: 1.4% C: 0.97%
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
| | O: 1.28% H: 1.32% C: 1.15%

treatment hiv commercialization
Gainers vs Losers
67% 33%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.